Differential regulation of the left and right coronary arteries of swine

Pharmacology

Volumn 77, Issue 3, 2006, Pages 137-143

  Crespo, Maria J ^a   Quidgley, José ^a   Dunbar, Donald C ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Coronary arteries; DL propranolol; Ketanserine; Serotonin; Vascular contractility

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXPROPRANOLOL; KETANSERIN TARTRATE; POTASSIUM CHLORIDE; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; DRUG EFFECT; DRY WEIGHT; HEART LEFT VENTRICLE WALL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LEFT CORONARY ARTERY; MALE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PERFUSION PRESSURE; PRIORITY JOURNAL; RECEPTOR DENSITY; REGULATORY MECHANISM; RIGHT CORONARY ARTERY; SWINE; TUNICA MEDIA;

ANIMALS; CORONARY VESSELS; KETANSERIN; MALE; POTASSIUM CHLORIDE; PROPRANOLOL; RECEPTORS, SEROTONIN, 5-HT1; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SEROTONIN ANTAGONISTS; SWINE; VASOCONSTRICTION;

EID: 33746381477     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093791     Document Type: Article

References (27)

1. Ding Z, Friedman MH: Dynamics of human coronary arterial motion and its potential role in coronary atherogenesis. J Biomech Eng 2000;122:488-492.
2. Cannon CP: Acute coronary syndromes: risk stratification and initial management. Cardiol Clin 2005;23:401-409.
3. Ray KK, Cannon CP: The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol 2005;46:1425-1433.
4. Amin Z, McElhinney DB, Moore P, Reddy VM, Hanley FL: Coronary arterial size late after the arterial inversion procedure for transposition of the greats arteries: implications for the arterial switch operation. J Thorac Cardiovasc Surg 2000;120:1047-1052.
5. Weaver ME, Pantely GA, Bristow JD, Ladley HD: A quantitative study of the anatomy and distribution of coronary arteries in swine in comparison with other animals and man. Cardiovascular Res 1986;20:907-917.
6. Sahni D, Jit I: Origin and size of the coronary arteries in the north-west Indians. Indian Heart J 1989;41:221-228.
7. Shimokawa H, Aarhus LL, Vanhoutte PM: Porcine coronary arteries with regenerated endothelium has a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res 1987;61:256-270.
8. Woodman OL, Dusting GJ: Involvement of nitric oxide in coronary vascular responses to 5-hydroxytryptamine in the anaesthetized greyhound. Clin Exp Pharmacol Physiol 1994;21:377-381.
9. Fam WM, McGregor M: Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ Res 1968;22:649-659.
10. Maseri A, L'Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, Severi S, Parodi O, Biagini A, Distante A, Pesola A: Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of 'preinfarction' angina. N Engl J Med 1978;299:1271-1277.
11. Bax WA, Renzenbrink GJ, Van Heuven-Nolsen D, Thijssen E, Bos E, Saxena PR: 5-HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacol 1993;239:203-210.
12. Satomura K, Takase B, Hamabe A, Ashida K, Hosaka H, Ohsuzu F, Kurita A: Sarpogrelate, a specific 5HT2-receptor antagonist, improves the coronary microcirculation in coronary artery disease. Clin Cardiol 2002;25:28-32.
13. Crespo MJ, Quidgley J: Statins decrease serotonin-induced contraction in coronary arteries of swine. Pharmacology 2006;76:141-147.
14. Crespo MJ, Moreta S, Gonzalez J: Cardiovascular deterioration in STZ-diabetic rats: possible role of vascular RAS. Pharmacology 2003;68:1-8.
15. Vatner SF: Regulation of coronary resistance vessels and large coronary arteries. Am J Cardiol 1985;56:16E-22E.
16. Ito T, Harada K, Tamura M, Takada G: In situ morphometric analysis of the coronary arterial growth in perinatal rats. Early Hum Dev 1998;52:21-26.
17. Frishman WH, Huberfeld S, Okin S, Wang Y, Kumar A, Shareef B: Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease. J Clin Pharmacol 1995;35:541-572.
18. Van Neuten JM: Serotonin and the blood vessel wall. J Cardiovasc Pharmacol 1985;7:S49-S51.
19. Gimbrone MA, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G: Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann NY Acad Sci 2000;902:230-239.
20. Vanhoutte PM, Luscher TF: Serotonin and the blood vessel wall. J Hypertens Suppl 1986;4:S29-S35.
21. Cushing DJ, Cohen ML: Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery. J Pharmacol Exp Ther 1992;261:856-862.
22. 2 receptor and calcium channel inhibitor LU49938 restores endothelium dependent responses in the regenerated endothelium of the porcine coronary artery. Cardiovasc Res 1995;29:95-101.
23. Nilsson T, Longmore J, Shaw D, Pantev E, Bard JA, Branchek T, Edvinsson L: Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol 1999;372:49-56.
24. Grover GJ, Sargent CA, Dzwonczyk S, Normandin DE, Antonaccio MJ: Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat hearts. J Cardiovasc Pharmacol 1993;22:664-672.
25. 2 receptor activation. Eur J Pharmacol 1989;161:91-94.
26. Chester AH, Martin GR, Bodelsson M, Arneklo-Nobin B, Tadjk-Arimi S, Tornebrandt K, Yacoub MH: 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res 1990;24:932-937.
27. Ratz PH, Berg KM, Urban NH, Miner AS: Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus. Am J Physiol Cell Physiol 2005;288:C769-C783.